Arcutis Biotherapeutics (ARQT) Insider Trading & Ownership $20.88 -0.03 (-0.14%) Closing price 04:00 PM EasternExtended Trading$20.91 +0.03 (+0.14%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$107.05KNumber OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$5.03M Get ARQT Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARQT Insider Buying and Selling by Quarter Arcutis Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/2/2025Larry Todd EdwardsInsiderSell4,504$20.04$90,260.16 10/2/2025Todd WatanabeInsiderSell20,739$20.04$415,609.56 10/1/2025Howard G WelgusDirectorSell10,000$18.92$189,200.00 10/1/2025Todd WatanabeInsiderSell24,261$19.33$468,965.13 9/9/2025Todd WatanabeInsiderSell504$17.52$8,830.08 9/8/2025Todd WatanabeInsiderSell9,625$17.54$168,822.50 9/4/2025Masaru MatsudaInsiderSell36,130$16.16$583,860.80 9/2/2025Howard G WelgusDirectorSell10,000$15.64$156,400.00 8/21/2025Patrick BurnettInsiderSell2,438$15.57$37,959.66 8/19/2025Patrick BurnettInsiderSell1,750$16.16$28,280.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/8/2025Patrick BurnettInsiderSell3,847$14.03$53,973.41 8/4/2025Latha VairavanCFOSell89$14.33$1,275.37 8/4/2025Masaru MatsudaInsiderSell6,330$14.33$90,708.90 8/4/2025Patrick BurnettInsiderSell2,622$14.33$37,573.26 8/4/2025Todd WatanabeInsiderSell11,547$14.33$165,468.51 8/1/2025Howard G WelgusDirectorSell10,000$14.30$143,000.00 7/14/2025Patrick BurnettInsiderSell5,750$15.07$86,652.50 7/10/2025Patrick BurnettInsiderSell23,000$15.05$346,150.00 6/18/2025Howard G WelgusDirectorSell10,139$13.37$135,558.43 6/13/2025Patrick J HeronDirectorBuy2,646$13.08$34,609.68 6/5/2025Patrick J HeronDirectorBuy378$13.41$5,068.98 6/4/2025Patrick J HeronDirectorBuy1,890$13.32$25,174.80 5/28/2025Masaru MatsudaInsiderSell1,800$13.78$24,804.00 5/21/2025Patrick J HeronDirectorBuy2,520$13.66$34,423.20 5/19/2025Larry Todd EdwardsInsiderSell7,451$14.07$104,835.57 5/8/2025Patrick BurnettInsiderSell3,871$13.59$52,606.89 5/2/2025Masaru MatsudaInsiderSell5,030$15.20$76,456.00 3/24/2025Todd Franklin WatanabeInsiderSell1,500$17.52$26,280.00 3/17/2025Todd Franklin WatanabeInsiderSell1,200$17.61$21,132.00 3/14/2025Patrick BurnettInsiderSell12,242$15.04$184,119.68 3/3/2025Howard G WelgusDirectorSell10,000$13.00$130,000.00 3/3/2025Patrick BurnettInsiderSell2,819$13.03$36,731.57 2/3/2025Howard G WelgusDirectorSell10,000$12.71$127,100.00 2/3/2025Masaru MatsudaInsiderSell8,338$12.70$105,892.60 1/2/2025Howard G WelgusDirectorSell10,000$14.67$146,700.00 12/31/2024Patrick BurnettInsiderSell1,691$14.00$23,674.00 12/20/2024Todd Franklin WatanabeInsiderSell15,000$15.17$227,550.00 12/2/2024Howard G WelgusDirectorSell10,000$12.51$125,100.00 11/30/2024Larry Todd EdwardsInsiderBuy1,093$7.11$7,771.23 11/22/2024Patrick BurnettInsiderSell16,023$10.14$162,473.22 11/19/2024Masaru MatsudaInsiderSell1,775$9.68$17,182.00 11/15/2024Patrick BurnettInsiderSell100$10.03$1,003.00 11/11/2024Terrie CurranDirectorSell8,687$10.85$94,253.95 11/4/2024Masaru MatsudaInsiderSell5,015$8.68$43,530.20 11/1/2024Howard G WelgusDirectorSell10,000$8.65$86,500.00 (Data available from 1/1/2013 forward) ARQT Insider Trading Activity - Frequently Asked Questions Who is on Arcutis Biotherapeutics' Insider Roster? The list of insiders at Arcutis Biotherapeutics includes David Joseph Topper, Howard G Welgus, Larry Todd Edwards, Latha Vairavan, Life Sciences Viii L Frazier, Masaru Matsuda, Patricia A Turney, Patrick Burnett, Patrick J Heron, Scott L Burrows, Terrie Curran, Todd Franklin Watanabe, and Todd Watanabe. Learn more on insiders at ARQT. What percentage of Arcutis Biotherapeutics stock is owned by insiders? 9.40% of Arcutis Biotherapeutics stock is owned by insiders. Learn more on ARQT's insider holdings. Which Arcutis Biotherapeutics insiders have been buying company stock? The following insiders have purchased ARQT shares in the last 24 months: Larry Todd Edwards ($7,771.23), Life Sciences Viii L Frazier ($200,000.00), and Patrick J Heron ($99,276.66). How much insider buying is happening at Arcutis Biotherapeutics? Insiders have purchased a total of 88,527 ARQT shares in the last 24 months for a total of $307,047.89 bought. Which Arcutis Biotherapeutics insiders have been selling company stock? The following insiders have sold ARQT shares in the last 24 months: David Joseph Topper ($110,214.48), Howard G Welgus ($1,631,658.43), Larry Todd Edwards ($300,990.18), Latha Vairavan ($1,275.37), Masaru Matsuda ($1,050,985.85), Patrick Burnett ($1,271,462.81), Terrie Curran ($94,253.95), Todd Franklin Watanabe ($274,962.00), and Todd Watanabe ($1,227,695.78). How much insider selling is happening at Arcutis Biotherapeutics? Insiders have sold a total of 437,466 Arcutis Biotherapeutics shares in the last 24 months for a total of $5,963,498.85 sold. Arcutis Biotherapeutics Key ExecutivesMr. Todd Franklin Watanabe M.A. (Age 56)President, CEO & Director Compensation: $1.01MDr. Bhaskar Chaudhuri Ph.D. (Age 69)Co-Founder & Independent Director Compensation: $60.83kDr. Patrick E. Burnett M.D. (Age 52)Ph.D., Senior VP & Chief Medical Officer Compensation: $722.94kMr. L. Todd Edwards (Age 60)Senior VP & Chief Commercial Officer Compensation: $755.64k2 recent tradesMr. David J. Topper (Age 66)Senior VP & Chief Financial Officer Mr. Rajvir MadanChief Digital & Technology OfficerMs. Latha VairavanVice President of Finance & Investor Relations1 recent tradesMs. Courtney Barton (Age 41)VP and Chief Compliance Officer & Privacy Officer Mr. Masaru Matsuda Esq. (Age 53)J.D., Senior VP, General Counsel & Corporate Secretary Compensation: $626.22k4 recent tradesMs. Amanda SheldonHead of Corporate Communications More Insider Trading Tools from MarketBeat Related Companies Verona Pharma PLC American Depositary Share Insider Ownership Revolution Medicines Insider Ownership Merus Insider Ownership Avidity Biosciences Insider Ownership Grifols Insider Ownership Cytokinetics Insider Ownership Rhythm Pharmaceuticals Insider Ownership CRISPR Therapeutics Insider Ownership Nuvalent Insider Ownership Axsome Therapeutics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Healthcare Companies Insiders Are Buying Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry This page (NASDAQ:ARQT) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcutis Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcutis Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
